Exploring the unconventional to provide hope: Dr Jason Williams at ASCO 2025

Oncology

Interview at ASCO 2025 with Dr Jason Williams

The Williams Cancer Institute specialises in minimally invasive procedures aimed at improving outcomes for patients with various types of cancers.

At ASCO 2025 in Chicago, pharmaphorum web editor Nicole Raleigh spoke with Dr Jason Williams, director of interventional oncology and immunotherapy at the Williams Cancer Institute, for a discussion on pioneering intra-tumoural immunotherapy and Pulsed Electric Field (PEF) therapy to reshape how tumours are treated.

Outside the conventional, Dr Williams provides his insights and opinions on emerging therapies in the field and discusses the Congress more broadly.

For this and other conversation from ASCO 2025, explore more here.

Nicole Raleigh

8 August, 2025

ASCO 25

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.